{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35694953", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "23"}, "DateRevised": {"Year": "2022", "Month": "06", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "22"}], "Language": ["eng"], "ELocationID": ["10.1039/d2ob00697a"], "Journal": {"ISSN": "1477-0539", "JournalIssue": {"Volume": "20", "Issue": "24", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "22"}}, "Title": "Organic & biomolecular chemistry", "ISOAbbreviation": "Org Biomol Chem"}, "ArticleTitle": "Cp*Co<sup>III</sup>-catalyzed formal [4 + 2] cycloaddition of 2-phenyl-1<i>H</i>-imidazoles to afford imidazo[1,2-<i>c</i>]quinazoline derivatives.", "Pagination": {"StartPage": "4993", "EndPage": "4998", "MedlinePgn": "4993-4998"}, "Abstract": {"AbstractText": ["A synthetic protocol based on Cp*Co<sup>III</sup>-catalyzed C-H amidation/annulation of 2-aryl-1<i>H</i>-imidazoles with 1,4,2-dioxazol-5-ones was developed to give imidazo[1,2-<i>c</i>]quinazoline derivatives with broad substrate scope in moderate to good yields. The method has good prospects of application in the synthesis of imidazo[1,2-<i>c</i>]quinazoline drugs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. dongyi@imm.ac.cn."}, {"Identifier": [], "Affiliation": "Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China."}], "LastName": "Wu", "ForeName": "Deyu", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. dongyi@imm.ac.cn."}, {"Identifier": [], "Affiliation": "Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China."}], "LastName": "Liu", "ForeName": "Zhengqiang", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. dongyi@imm.ac.cn."}, {"Identifier": [], "Affiliation": "Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China."}], "LastName": "Chang", "ForeName": "Yiting", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. dongyi@imm.ac.cn."}, {"Identifier": [], "Affiliation": "Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China."}], "LastName": "Chen", "ForeName": "Jiajing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. dongyi@imm.ac.cn."}, {"Identifier": [], "Affiliation": "Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China."}], "LastName": "Qi", "ForeName": "Haixiang", "Initials": "H"}, {"Identifier": ["0000-0001-7844-7206"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. dongyi@imm.ac.cn."}, {"Identifier": [], "Affiliation": "Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medcial University, Guiyang 550014, China."}], "LastName": "Dong", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": ["0000-0002-1720-5286"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. dongyi@imm.ac.cn."}, {"Identifier": [], "Affiliation": "Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China."}], "LastName": "Xu", "ForeName": "Heng", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Org Biomol Chem", "NlmUniqueID": "101154995", "ISSNLinking": "1477-0520"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Imidazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinazolines"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Catalysis"}, {"QualifierName": [], "DescriptorName": "Cycloaddition Reaction"}, {"QualifierName": [], "DescriptorName": "Imidazoles"}, {"QualifierName": [], "DescriptorName": "Quinazolines"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2022", "Month": "6", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "13", "Hour": "4", "Minute": "36"}], "PublicationStatus": "epublish", "ArticleIdList": ["35694953", "10.1039/d2ob00697a"]}}], "PubmedBookArticle": []}